Ubrigene Biosciences Inc.

Ubrigene Biosciences Inc. company information, Employees & Contact Information

uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA). Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. With four Centers of Excellence in North America, and Asia Pacific and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.
Looking for a particular Ubrigene Biosciences Inc. employee's phone or email?

Ubrigene Biosciences Inc. Questions

News

uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development - BioInformant

uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development BioInformant

uBriGene Unveils V2.0 RNA-LNP iPSC Reprogramming Kit Optimized for PBMCs and Hard-to-Reprogram Cells - Yahoo Finance

uBriGene Unveils V2.0 RNA-LNP iPSC Reprogramming Kit Optimized for PBMCs and Hard-to-Reprogram Cells Yahoo Finance

uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy - Newswire.com

uBriGene Biosciences Congratulates Strategic Partner InnoVec Biotherapeutics on FDA Clearance of IND for IVB103, an AAV-Based Gene Therapy Newswire.com

uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development - BioSpace

uBriGene Launches Clinical iPSC Banks to Accelerate Regenerative Medicine and Cell Therapy Development BioSpace

Cell therapy weekly: uBriGene moves into the US market with GMP facility acquisition - RegMedNet

Cell therapy weekly: uBriGene moves into the US market with GMP facility acquisition RegMedNet

uBriGene steps into US with Mustang Bio facility buy - BioProcess International

uBriGene steps into US with Mustang Bio facility buy BioProcess International

Mustang Bio buys back assets from Chinese company after federal review - The Business Journals

Mustang Bio buys back assets from Chinese company after federal review The Business Journals

uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit - BioSpace

uBriGene Biosciences Submits Drug Master File for iPSC Reprogramming mRNA-LNP Kit BioSpace

Top Ubrigene Biosciences Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant